Benefit of Paramedical Care in Accompanying Caregivers of Patients That Had Surgery for an Head and Neck Invasive Cancer

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Head and Neck invasive cancer usually requires surgery that is associated with modifications of the body structure of patient regarding breathing, eating and communication. These modifications are correlated with an important loss of autonomy in patients. During the study, while the patient is hospitalised after the surgery, the paramedical team will train the caregiver of the patient from experimental group a new dimension of autonomy in order to assure a safe return home. The level of learning depends on each caregiver and patient; therefore, an adapted training is provided. This study evaluates the impact of paramedical care in accompanying caregivers of patients that had surgery for an ENT invasive cancer, by comparing the experimental group (paramedical care) to the standard group (standard care). The hypothesis of the study is that a benefit will be seen in the experimental group, by reducing the caregiver burden, improving the quality of life of patients and lowering the rate of hospitalisations and prolonged hospitalisations in these patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Age between 18 and 85 years old

• ECOG ≤ 2

• Patient diagnosed with an head and neck squamous-cell carcinoma, stage T2-T4/N+, non-metastatic, localised at larynx, pharynx, oropharynx, oral cavity or maxillary, needing curative surgery, with indication of radiotherapy after surgery, in accordance to decision of the regular multidisciplinary meetings in cancerology

• No ongoing measure of corrective justice for the patient

• Informed consent form signed

• Patient covered by health system

Locations
Other Locations
France
Centre Henri Becquerel
RECRUITING
Rouen
Contact Information
Primary
Yveline David
yveline.david@chb.unicancer.fr
+33232082542
Backup
Doriane Richard
doriane.richard@chb.unicancer.fr
+33232082985
Time Frame
Start Date: 2022-10-31
Estimated Completion Date: 2027-10-31
Participants
Target number of participants: 76
Treatments
Experimental: Accompanying caregivers by paramedical team
No_intervention: No dedicated accompanying by medical team
Related Therapeutic Areas
Sponsors
Leads: Centre Henri Becquerel

This content was sourced from clinicaltrials.gov